Apolipoprotein E4, inhibitory network dysfunction, and Alzheimer’s disease
Abstract Apolipoprotein (apo) E4 is the major genetic risk factor for Alzheimer’s disease (AD), increasing risk and decreasing age of disease onset. Many studies have demonstrated the detrimental effects of apoE4 in varying cellular contexts. However, the underlying mechanisms explaining how apoE4 l...
Main Authors: | Ramsey Najm, Emily A. Jones, Yadong Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-06-01
|
Series: | Molecular Neurodegeneration |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13024-019-0324-6 |
Similar Items
-
Loss of GABAergic inputs in APP/PS1 mouse model of Alzheimer's disease
by: Tutu Oyelami, et al.
Published: (2014-04-01) -
Inhibitory hippocampus-medial septum projection controls locomotion and exploratory behavior
by: Yuh-Tarng Chen, et al.
Published: (2023-04-01) -
GABAergic Inhibitory Interneuron Deficits in Alzheimer’s Disease: Implications for Treatment
by: Yilan Xu, et al.
Published: (2020-06-01) -
Inhibitory or excitatory? Optogenetic interrogation of the functional roles of GABAergic interneurons in epileptogenesis
by: Hui Ye, et al.
Published: (2017-12-01) -
Dual midbrain and forebrain origins of thalamic inhibitory interneurons
by: Polona Jager, et al.
Published: (2021-02-01)